The Experiences of Drug List Formulation Procedure Based on Pharmaeconomics and the Enlightenment to China
- VernacularTitle:基于经济性评价的药品遴选经验介绍及对我国的启示
- Author:
Jia-Jun QIAO
1
;
Yi-Ni ZENG
;
Hong-Peng FU
Author Information
- Keywords: pharmaeconomics evaluation; drug list; medical insurance; review
- From: Chinese Health Economics 2018;37(10):94-96
- CountryChina
- Language:Chinese
- Abstract: Objectives: To analyze the role of pharmaeconomics during drug list formulation procedure and the enlightenment to China. Methods: Using literature review and comparative analysis method, it compared the drug list formulation procedure of WHO, Australia, UK, Tailand and the role of pharmaeconomics. Results: Using pharmaeconomics method was common in international experience. The methodology of pharmaeconomics was also well developed. Conclusions: To improve China drug selection procedure, China should enhance government policy invest in pharmaeconomics usage and support the research, break down the grey benefit relation between medicine and medical.
